RankAlpha logo
Back to Rankings

ALKS

AlkermesA
Nasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
Quote time unavailable
View Chart
+
Peers tracked
9
U.S. public peers
Grade Position
Above peers
vs peer average
ALKS vs peer average
94/100
ALKS vs. peer average (A vs. D)
Grade spread
B 1 · C 2 · D 4 · F 2
Graded peers loaded
Coverage
9 graded
100% of tracked

Peer overview

LQDA is the first available peer comparator.

Same-sector mid-cap biotech candidate, but the packet does not establish sufficient indication or commercial overlap for a tight valuation comparison.

Peer source comes from the stored AI memo or peer model
Grades and factor rows use RankAlpha API data when available
Missing peer scores remain blank instead of being estimated
Side-by-side comparison keeps the data contract visible
Top peerLQDALiquidia
ALKS
Alkermes
LQDA
Liquidia
Grade
A
B
Momentum
30
18
Value
60
58
Sentiment
78
73
Setup Bias
Net —
-
Market Cap
-
-
Posture
Constructive
Constructive

Grade position vs LQDA

ALKS / LQDA
Grade Position
Above peers
ALKS vs. peer average (A vs. D)
94/100
Momentum
30
ALKS
Value
60
ALKS
Sentiment
78
ALKS

Rotation landscape

Peers ranked by the order returned from the peer source, with grades from the API.

Rank
Ticker
Company
Grade
Grade score
vs ALKS
1
LQDA
LQDA
B
80/100
+1
2
IMVT
IMVT
D
40/100
+3
3
IBRX
ImmunityBio Inc Common
C
60/100
+2
4
TWST
Twist Bioscience Corp Common
F
20/100
+4
5
RYTM
Rhythm Pharmaceuticals Inc Common
D
40/100
+3
LQDA is the first peer returned for this comparison set.